Phosphorylation of 4E‐BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila

No abstract is available for this paper.

• Publication year

  2008

• Venue

  EMBO Journal

• Publication date

  2008-09-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/emboj.2008.163PMID 18701920PMCID PMC2543051
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ATF4-mediated induction of 4E-BP1 contributes to pancreatic beta cell survival under endoplasmic reticulum stress.

  2008cited by this paper
• Oxidative Stress in Parkinson's Disease

  2008cited by this paper
• Dispensable role of Drosophila ortholog of LRRK2 kinase activity in survival of dopaminergic neurons

  2008cited by this paper
• A Drosophila model for LRRK2-linked parkinsonism

  2008cited by this paper
• eIF4E function in somatic cells modulates ageing in Caenorhabditis elegans

  2007cited by this paper
• Loss of LRRK2/PARK8 induces degeneration of dopaminergic neurons in Drosophila.

  2007cited by this paper
• LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity.

  2007cited by this paper
• Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.

  2006cited by this paper
• Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin.

  2006cited by this paper
• LRRK2 in Parkinson's disease: protein domains and functional insights.

  2006cited by this paper
• The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity.

  2006cited by this paper
• LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?

  2006cited by this paper
• Molecular pathophysiology of Parkinson's disease.

  2005cited by this paper
• 4E-BP functions as a metabolic brake used under stress conditions but not during normal growth.

  2005cited by this paper
• Translational control in stress and apoptosis

  2005cited by this paper
• Regulation of cap-dependent translation by eIF4E inhibitory proteins

  2005cited by this paper
• Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity.

  2005cited by this paper
• Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.

  2005cited by this paper
• Starvation and oxidative stress resistance in Drosophila are mediated through the eIF4E-binding protein, d4E-BP.

  2005cited by this paper
• Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling.

  2005influential reference
• Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.

  2004cited by this paper
• Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.

  2004cited by this paper
• PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila.

  2004cited by this paper
• Dysregulation of the TSC-mTOR pathway in human disease

  2004cited by this paper
• The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis

  2004cited by this paper
• Similar gene expression patterns characterize aging and oxidative stress in Drosophila melanogaster.

  2004cited by this paper
• Rheb promotes cell growth as a component of the insulin/TOR signalling network

  2003cited by this paper
• Oxidative stress in Parkinson's disease

  2003cited by this paper
• An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin.

  2001cited by this paper
• Putative Transmembrane Polypeptide , which Can Lead to Endoplasmic Reticulum Stress , Is a Substrate of Parkin

  2001cited by this paper
• Regulation of translation initiation by FRAP/mTOR.

  2001influential reference
• Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size.

  2001cited by this paper
• TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth.

  2001cited by this paper
• The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila

  2001cited by this paper
• Hierarchical phosphorylation of the translation inhibitor 4E-BP1.

  2001influential reference
• A Drosophila model of Parkinson's disease

  2000cited by this paper
• Drosophila Thor participates in host immune defense and connects a translational regulator with innate immunity.

  2000influential reference
• Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity*

  2000cited by this paper
• eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation.

  1999cited by this paper
• Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism.

  1999cited by this paper
• Insulin-stimulated kinase from rat fat cells that phosphorylates initiation factor 4E-binding protein 1 on the rapamycin-insensitive site (serine-111).

  1998cited by this paper
• Identification of Phosphorylation Sites in the Translational Regulator, PHAS-I, That Are Controlled by Insulin and Rapamycin in Rat Adipocytes*

  1997cited by this paper
• Eukaryotic mRNA cap binding protein: purification by affinity chromatography on sepharose-coupled m7GDP.

  1979cited by this paper

• Genetic evidence for a functional association between Parkinson’s disease proteins leucine-rich repeat kinase 2 and α-synuclein during axonal transport

  2026influential citation
• An Adipose mTORC1 Effector Links Nutrient-induced Ribosomal Protein Translation to Lifespan in Drosophila

  2025cites this paper
• Identification of Key Active Constituents in Eucommia ulmoides Oliv. Leaves Against Parkinson’s Disease and the Alleviative Effects via 4E-BP1 Up-Regulation

  2025cites this paper
• The 4E-BPs as Translational Regulators in Neurological Disorders: Molecular Mechanisms and Therapeutic Potential

  2025cites this paper
• LRRK2 in Drosophila Melanogaster Model: Insights into Cellular Dysfunction and Neuroinflammation in Parkinson’s Disease

  2025influential citation
• The AMPK-FOXO signaling regulates the transcriptional response of 4EBP to pesticide stress in Tribolium castaneum.

  2025cites this paper
• The Multifaceted Role of LRRK2 in Parkinson’s Disease

  2025cites this paper
• The translational inhibitor 4EBP/Thor is required for Drosophila adaptation to hypoxia

  2025cites this paper
• Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrils

  2025influential citation
• Parkinson’s Disease Associated with Mutations in the LRRK2 Gene: Approaches to Therapy

  2025cites this paper
• LRRK2 Kinase Inhibitor PF-06447475 Protects Drosophila melanogaster against Paraquat-Induced Locomotor Impairment, Life Span Reduction, and Oxidative Stress

  2024cites this paper
• Experimental models of Parkinson's disease: Challenges and Opportunities.

  2024cites this paper
• Protein Translation in the Pathogenesis of Parkinson’s Disease

  2024cites this paper
• Post-translational modification and mitochondrial function in Parkinson’s disease

  2024cites this paper
• Effects of AMPK Stimulation on the Pathogenesis and Progression of Parkinson’s Disease

  2023cites this paper
• Function and regulation of nitric oxide signaling in Drosophila

  2023influential citation
• LRRK2 Attenuates Antioxidant Response in Familial Parkinson’s Disease Derived Neural Stem Cells

  2023cites this paper
• Parkinson’s Disease: Exploring Different Animal Model Systems

  2023cites this paper
• mTORC1-Dependent Protein and Parkinson’s Disease: A Mendelian Randomization Study

  2023cites this paper
• Phosphorylated S6K1 and 4E-BP1 play different roles in constitutively active Rheb-mediated retinal ganglion cell survival and axon regeneration after optic nerve injury

  2023cites this paper
• Overview of the Impact of Pathogenic LRRK2 Mutations in Parkinson’s Disease

  2023cites this paper
• Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson’s disease

  2023cites this paper
• Redox Modulation of Mitochondrial Proteins in the Neurotoxicant Models of Parkinson's Disease

  2022cites this paper
• Activation of the Mitochondrial Unfolded Protein Response: A New Therapeutic Target?

  2022cites this paper
• Parkinson disease-associated Leucine-rich repeat kinase regulates UNC-104-dependent axonal transport of Arl8-positive vesicles in Drosophila

  2022cites this paper
• Drosophila ZIP13 over‐expression or transferrin1 RNAi influences the muscle degeneration of Pink1 RNAi by elevating iron levels in mitochondria

  2022cites this paper
• Structural Insights and Development of LRRK2 Inhibitors for Parkinson’s Disease in the Last Decade

  2022cites this paper
• Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s Disease

  2022cites this paper
• Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches

  2022cites this paper
• LRRK2 Phosphorylates Neuronal Elav RNA-Binding Proteins to Regulate Phenotypes Relevant to Parkinson’s Disease

  2022cites this paper
• A Systematic review of various in-vivo screening models as well as the mechanisms involved in Parkinson's disease screening procedures.

  2022cites this paper
• Local Translation in Nervous System Pathologies

  2021cites this paper
• Dopamine neuron-specific LRRK2 G2019S effects on gene expression revealed by translatome profiling.

  2021cites this paper
• LncRNAs as putative biomarkers and therapeutic targets for Parkinson’s disease

  2021cites this paper
• Effects and potential mechanisms of rapamycin on MPTP-induced acute Parkinson's disease in mice.

  2021cites this paper
• Modeling Parkinson’s Disease: Not Only Rodents?

  2021cites this paper
• High altitude regulates the expression of AMPK pathways in human placenta.

  2021cites this paper
• Proteotoxic stress is a driver of the loser status and of cell competition

  2021cites this paper
• Parkinson's disease and microRNAs - Lessons from model organisms and human studies.

  2021cites this paper
• The cell biology of Parkinson’s disease

  2021cites this paper
• Drosophila as a model to study autophagy in neurodegenerative diseases and digestive tract

  2021cites this paper
• LRRK2 at the Crossroad of Aging and Parkinson’s Disease

  2021cites this paper
• Oligomerization of Lrrk controls actin severing and α-synuclein neurotoxicity in vivo

  2021influential citation
• Dysregulated mRNA Translation in the G2019S LRRK2 and LRRK2 Knock-Out Mouse Brains

  2021cites this paper
• Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection

  2021cites this paper
• Advancement in the modelling and therapeutics of Parkinson's disease.

  2020cites this paper
• Defects in mRNA Translation in LRRK2-Mutant hiPSC-Derived Dopaminergic Neurons Lead to Dysregulated Calcium Homeostasis.

  2020influential citation
• Attenuation of epigenetic regulator SMARCA4 and ERK‐ETS signaling suppresses aging‐related dopaminergic degeneration

  2020cites this paper
• Genetic and Environmental Factors Influence the Pleomorphy of LRRK2 Parkinsonism

  2020cites this paper
• Biomarker detection of Parkinson’s disease: therapy and treatment using nanomaterials

  2020cites this paper
• Pathological Functions of LRRK2 in Parkinson’s Disease

  2020cites this paper
• Implications of mRNA translation dysregulation for neurological disorders.

  2020cites this paper
• Maintenance of mitochondrial integrity in midbrain dopaminergic neurons governed by a conserved developmental transcription factor

  2020cites this paper
• Targeting UCH in Drosophila melanogaster as a model for Parkinson's disease.

  2020cites this paper
• Translation Regulation by eIF2α Phosphorylation and mTORC1 Signaling Pathways in Non-Communicable Diseases (NCDs)

  2020cites this paper
• Leucine-rich repeat kinase 2 (LRRK2) and Parkinson's disease: from genetics to pathobiology

  2020cites this paper
• Protein synthesis is suppressed in sporadic and familial Parkinson’s Disease by LRRK2

  2020cites this paper
• 9-Methyl-β-carboline inhibits monoamine oxidase activity and stimulates the expression of neurotrophic factors by astrocytes

  2020cites this paper
• Hematopoietic Stem and Progenitor Cells Exhibit Stage-Specific Translational Programs via mTOR- and CDK1-Dependent Mechanisms.

  2020cites this paper
• Small molecule H89 renders the phosphorylation of S6K1 and AKT resistant to mTOR inhibitors

  2020cites this paper
• Pathways of protein synthesis and degradation in PD pathogenesis.

  2020cites this paper
• Dietary Amino Acids Impact LRRK2-Induced Neurodegeneration in Parkinson's Disease Models

  2020influential citation
• 4E-BP1 Protects Neurons from Misfolded Protein Stress and Parkinson's Disease Toxicity by Inducing the Mitochondrial Unfolded Protein Response

  2020cites this paper
• Linking the leucine-rich repeat kinase 2 gene, animal models, and Parkinson's disease

  2020cites this paper
• LRRK2-Related Parkinson’s Disease Due to Altered Endolysosomal Biology With Variable Lewy Body Pathology: A Hypothesis

  2020cites this paper
• Mechanisms Linking Mitochondrial Dysfunction and Proteostasis Failure.

  2020cites this paper
• Progress in LRRK2-Associated Parkinson’s Disease Animal Models

  2020influential citation
• LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same

  2019cites this paper
• Autophagy and LRRK2 in the Aging Brain

  2019cites this paper
• Light-driven activation of mitochondrial proton-motive force improves motor behaviors in a Drosophila model of Parkinson’s disease

  2019cites this paper
• mGluR5 Allosteric Modulation Promotes Neurorecovery in a 6-OHDA-Toxicant Model of Parkinson’s Disease

  2019cites this paper
• Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson’s disease

  2019cites this paper
• LRRK2 Signalling Pathways in Parkinson’s Disease

  2019cites this paper
• BENZOTHIAZOLE-BASED LRRK2 INHIBITORS AS WNT ENHANCERS AND PROMOTERS OF OLIGODENDROCYTIC FATE.

  2019cites this paper
• Structural aspects of the regulation of Parkinson's Disease-associated LRRK2 Kinase by Rab GTPases

  2019influential citation
• Rab GTPases as Physiological Substrates of LRRK2 Kinase

  2019cites this paper
• Upregulation of the p53-p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of α-synuclein

  2019cites this paper
• Non-Cell Autonomous Mechanism of Parkinson's Disease Pathology Caused by G2019S LRRK2 Mutation in Ashkenazi Jewish Patient: Single Cell Analysis.

  2019cites this paper
• Increased translation as a novel pathogenic mechanism in Huntington's disease.

  2019cites this paper
• Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson’s disease

  2019cites this paper
• A Neuron-Glial Trans-Signaling Cascade Mediates LRRK2-Induced Neurodegeneration

  2019cites this paper
• Targeting mRNA translation in Parkinson's disease.

  2019cites this paper
• Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection

  2019cites this paper
• Modeling of Human Parkinson’s Disease in Fly

  2019cites this paper
• LRRK2 and mitochondria: Recent advances and current views.

  2019cites this paper
• Identification of PP2A and S6 Kinase as Modifiers of Leucine-Rich Repeat Kinase-Induced Neurotoxicity

  2019cites this paper
• FOXO3a expression and its diagnostic value in pancreatic ductal adenocarcinoma.

  2018cites this paper
• Modeling Parkinson’s Disease in Drosophila: What Have We Learned for Dominant Traits?

  2018influential citation
• The LRRK2 signalling system

  2018cites this paper
• 4 Modeling LRRK 2 Parkinsonism

  2018cites this paper
• Drosophila as a Neurotoxicological Model

  2018cites this paper
• Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics

  2018cites this paper
• Exploring the functional impact of mutational drift in LRRK2 gene and identification of specific inhibitors for the treatment of Parkinson disease

  2018cites this paper
• mTOR/AMPK signaling in the brain: Cell metabolism, proteostasis and survival.

  2018cites this paper
• P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity.

  2018cites this paper
• Chapter 7 The Potential of Targeting LRRK 2 in Parkinson ’ s Disease

  2018cites this paper
• lncRNA MALAT1/miR-205-5p axis regulates MPP+-induced cell apoptosis in MN9D cells by directly targeting LRRK2.

  2018cites this paper
• Drosophila Models of Sporadic Parkinson’s Disease

  2018cites this paper
• Effect of leucine-rich repeat kinase 2 (LRRK2) on protein synthesis

  2018influential citation
• Parkinson's Disease Model.

  2018cites this paper